Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Conditions

• Solid Tumors
• Ovarian Cancer
• Endometrial Cancer

Interventions

• DRUG: ARQ 092 + carboplatin + paclitaxel (Closed)
• DRUG: ARQ 092 + paclitaxel (Closed)
• DRUG: ARQ 092 + anastrozole

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)